Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesShire Secures European Wide Label Extension for FOSRENOL in Chronic Kidney Disease
Shire, 10/29/09
Shire plc, the global specialty biopharmaceutical company, announced it has received approval through the European Mutual Recognition Procedure for an extension to the current indication for FOSRENOL, paving the way to make the non–calcium, non–resin phosphate binder available throughout the EU to control hyperphosphataemia in chronic kidney disease patients who are not on dialysis with a serum phosphorus level >1.78mmol/L.
Today in Drug Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Boston Scientific Announces FDA Clearance and CE Mark for WallFlex Fully Covered Esophageal Stent
Boston Scientific, 11/24/09
Dendreon Receives FDA Acknowledgement of Complete Response
Dendreon Coproration, 11/23/09
ImmunoGen, Inc. Announces Second License Taken by Amgen for Right to Use the Companys TAP Technology
ImmunoGen, Inc., 11/20/09
Sponsor
Article Search
Sponsor